Literature DB >> 8606126

Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment.

K Laitinen1, A L Laurila, M Leinonen, P Saikku.   

Abstract

Reactivation of Chlamydia pneumoniae infection was studied by inducing immunosuppression by cortisone acetate treatment given every other day for 14 days in intranasally infected NIH/s mice. The treatment started 2 or 4 weeks after primary infection, when no C. pneumoniae was detected. C. pneumoniae could be recovered from the lung cultures on days 7 and 9 in 10 and 60% of the mice, respectively, when cortisone treatment was begun 30 days after infection. These results confirm the persistent nature of C. pneumoniae infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606126      PMCID: PMC173951          DOI: 10.1128/iai.64.4.1488-1490.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

2.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

3.  Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig.

Authors:  R J Gryglewski; B Panczenko; R Korbut; L Grodzinska; A Ocetkiewicz
Journal:  Prostaglandins       Date:  1975-08

Review 4.  The epidemiology and significance of Chlamydia pneumoniae.

Authors:  P Saikku
Journal:  J Infect       Date:  1992-07       Impact factor: 6.072

5.  The effect of in vivo hydrocortisone on subpopulations of human lymphocytes.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

6.  An epidemic of infections due to Chlamydia pneumoniae in military conscripts.

Authors:  M R Ekman; J T Grayston; R Visakorpi; M Kleemola; C C Kuo; P Saikku
Journal:  Clin Infect Dis       Date:  1993-09       Impact factor: 9.079

7.  Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain.

Authors:  C C Kuo; A M Gown; E P Benditt; J T Grayston
Journal:  Arterioscler Thromb       Date:  1993-10

8.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

9.  Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone.

Authors:  R Malinverni; C C Kuo; L A Campbell; J T Grayston
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

10.  Glucocorticoid suppression of macrophage migration inhibitory factor.

Authors:  J E Balow; A S Rosenthal
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

View more
  16 in total

1.  Analysis of Chlamydia pneumoniae growth in cells by reverse transcription-PCR targeted to bacterial gene transcripts.

Authors:  Shusaku Haranaga; Hideaki Ikejima; Hiroyuki Yamaguchi; Herman Friedman; Yoshimasa Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.

Authors:  Dario Caronzolo; Valeria Lucini; Marilou Pannacci; Silvia Grosso; Federica Colleoni; Franco Fraschini; Francesco Scaglione
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood.

Authors:  Hiroyuki Yamaguchi; Ichiro Oshio; Takako Osaki; Satoru Kurata; Yoshimasa Yamamoto; Shigeru Kamiya
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

4.  Reactivation of chlamydial genital tract infection in mice.

Authors:  T W Cotter; G S Miranpuri; K H Ramsey; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells.

Authors:  G I Byrne; S P Ouellette; Z Wang; J P Rao; L Lu; W L Beatty; A P Hudson
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Hannu Alakärppä; Denise Bem David; Maija Leinonen; Pekka Saikku
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection.

Authors:  J M Penttilä; M Anttila; M Puolakkainen; A Laurila; K Varkila; M Sarvas; P H Mäkelä; N Rautonen
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit.

Authors:  Mika Paldanius; Aini Bloigu; Maija Leinonen; Pekka Saikku
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

Review 9.  Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Front Cell Infect Microbiol       Date:  2014-03-21       Impact factor: 5.293

Review 10.  Laboratory diagnosis of persistent human chlamydial infection.

Authors:  Mirja Puolakkainen
Journal:  Front Cell Infect Microbiol       Date:  2013-12-17       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.